Yoshimura Akihiro 吉村彰紘

Researcher Number	10927221
Other IDs	https://orcid.org/0000-0002-3753-2110
Affiliation (Current)	2025: 京都府立医科大学, 医学(系)研究科(研究院), 研修員
Affiliation (based on the past Project Information) *help	2023: 京都府立医科大学, 医学(系)研究科(研究院), 研修員 2022: 京都府立医科大学, 医学(系)研究科(研究院), 特任助教
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related
Keywords	Principal Investigator AXL / 治療抵抗性 / 分子標的薬治療 / 肺がん / コンパニオン診断法

Research Projects
(1 results)
Research Products
(2 results)

Novel companion diagnostics of drug resistance to molecularly targeted therapy in lung cancerPrincipal Investigator
- Principal Investigator
  
  Yoshimura Akihiro
- Project Period (FY)
  2022 – 2023
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Kyoto Prefectural University of Medicine

All Journal Article Presentation

[Journal Article] High levels of <scp>AXL</scp> expression in untreated <scp> <i>EGFR</i> </scp> ‐mutated non‐small cell lung cancer negatively impacts the use of osimertinib2022
- Author(s)
  Yoshimura A、Yamada T、Serizawa M、Uehara H、Tanimura K、Okuma Y、Fukuda A、Watanabe S、Nishioka N、Takeda T、Chihara Y、Takemoto S、Harada T、Hiranuma O、Shirai Y、Shukuya T、Nishiyama A、Goto Y、Shiotsu S、Kunimasa K、Morimoto K、Katayama Y、Suda K、Mitsudomi T、Yano S、Kenmotsu H、Takahashi T、Takayama K
- Journal Title
  
  Cancer Science
  
  Volume: 114 Issue: 2 Pages: 606-618
- DOI
  10.1111/cas.15608
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K15588
[Presentation] 未治療EGFR遺伝子変異陽性非小細胞肺がんを対象としたオシメルチニブ治療効果と腫瘍内AXL発現に関する検討2022
- Author(s)
  吉村彰紘
- Organizer
  第26回日本がん分子標的治療学会学術集会
- Data Source
  KAKENHI-PROJECT-22K15588